Clinical monitoring of Desflurane during CPB

Analysis of blood concentration of desflurane during cardiopulumonary bypass

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs041190132

Enrollment

Registered

2020-03-31

Start date

2020-03-31

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Valvular heart disease, Ischemic heart disease

Interventions

Blood sampling

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Valvular heart disease, Ischemic heart disease 2. Cardiopulmonary bypass with mild hypothermia 3. Age: 40~90 4. ASA PS 1~3 5. Patients with informed consent

Exclusion criteria

Exclusion criteria: 1. Emergency surgery 2. Pregnant or breastfeedin woman 3. High degree low temperature CPB 4. %VC is below 80% 5. In case the special judgement by the researcher

Design outcomes

Primary

Measure	Time frame
Blood concentration of Desflurane 30 min after administration during CPB	—

Secondary

Measure	Time frame
Blood concentration of Desflurane 0, 5, 60 min after administration during CPB Gas sampling of Desflurane during CPB Blood flow volume and pressure during CPB BIS value during CPB	—

Contacts

Public ContactHidenori Suzuki

Mie University Hospital

rin-shomasui@clin.medic.mie-u.ac.jp+81-59-231-5634

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026